If approved by the FDA, NARCAN Nasal Spray will be the first 4 mg naloxone nasal spray switched from prescription status to over-the-counter use GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- ...
(The Hill) – Emergent BioSolutions Inc., the maker of narcotic overdose treatment Narcan, said on Tuesday that the Food and Drug Administration (FDA) has accepted its application to grant priority ...
GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® ...
Starting July 1, 2025, additional opioid overdose response tools will be available to continue addressing evolving patient and customer needs to combat public health crisis GAITHERSBURG, Md., July 02, ...
Emergent BioSolutions Inc. has expanded its NARCANDirect® online distribution network to include KLOXXADO® (naloxone HCl) Nasal Spray 8 mg, enhancing access to opioid overdose response products for ...
A man holds a naloxone kit given to him at a methodone clinic in 2022 in Santa Ana. (Gary Coronado / Los Angeles Times) California residents are now eligible to buy naloxone — a drug commonly sold ...
SAN FRANCISCO (KRON) — Governor Gavin Newsom announced Tuesday that California is the first state to sell a generic version of overdose reversal drug Narcan directly to residents for $24 per twin pack ...
GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announces its recognition of the U.S. House of Representatives for adding over-the-counter (OTC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback